Company / Depreciation & Amortization
Bionano Genomics, Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$9.5M
FY2025
5-year range
$3.4M / $14.0M
FY2021-FY2025
Trend
-32.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $14M to $10M over the past 2 years.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +45.1%.
Improved from $14M to $10M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- +45.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +45.1%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 32.1% year-over-year.
- Peak depreciation & amortization was recorded in FY2024.
- Lowest depreciation & amortization in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.5M | -32.1% |
| FY2024 | $14.0M | +2.3% |
| FY2023 | $13.7M | +42.5% |
| FY2022 | $9.6M | +187.1% |
| FY2021 | $3.4M | +126.6% |
| FY2020 | $1.5M | +31.1% |
| FY2019 | $1.1M | -14.6% |
| FY2018 | $1.3M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026